The earnings call presented robust growth in revenue and test volumes across several regions, particularly in Egypt and Saudi Arabia. Profitability metrics showed significant improvement. However, challenges remain in Sudan and the current contribution from Saudi operations is still minimal.

Company Guidance

During IDH's third-quarter earnings call for 2025, the company reported a strong financial performance, highlighted by a 41% year-on-year revenue growth for the first nine months, driven by a 10% increase in test volumes across all operating geographies and a 28% rise in average revenue per test. The company also saw its EBITDA margin expand to 35% from 30% the previous year, largely due to operational efficiencies and cost management, which resulted in a decrease in COGS and SG&A as a share of revenue. Egypt remained the core market, contributing 84% of total revenues, while the Saudi operations showed promising growth potential with revenues more than quadrupling year-on-year. IDH reiterated its full-year guidance, expecting over 35% revenue growth and an EBITDA margin above 30% for 2025. The company also emphasized continued geographic expansion, particularly with 103 new branches added in Egypt over the past year, and a strategic focus on radiology and specialized diagnostics.

Strong Revenue Growth

IDH reported a 41% revenue growth year-on-year for the first 9 months of 2025.

Increased Test Volumes and Revenue per Test

Test volumes increased by 10%, and average revenue per test rose 28% year-on-year.

Expansion in Egypt

103 new branches were added in Egypt, increasing the total to 670 locations.

Saudi Operations Growth

Revenues in Saudi Arabia more than quadrupled compared to the same period last year.

Profitability Improvements

EBITDA margin expanded to 35% from 30% last year; gross profit margin rose to 43% from 38%.

Positive EBITDA in Nigeria

Echo-Lab in Nigeria remained positive on EBITDA throughout the 9-month period.

Integrated Diagnostics Holdings (GB:IDHC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

GB:IDHC Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Apr 16, 2026	2025 (Q4)	- / -	―	―	―	―
Nov 13, 2025	2025 (Q3)	- / -	0.008	―	―	―
Sep 02, 2025	2025 (Q2)	- / -	0.004	―	―	―
May 28, 2025	2025 (Q1)	- / -	0.167	―	―	―
Apr 17, 2025	2024 (Q4)	- / -	0.167	―	―	―
Nov 14, 2024	2024 (Q3)	- / <0.01	0.3	-97.33% (-0.29)	―	―
Aug 28, 2024	2024 (Q2)	- / <0.01	0.08	-95.00% (-0.08)	―	―
May 30, 2024	2024 (Q1)	- / 0.17	0.29	-42.41% (-0.12)	―	―
Mar 28, 2024	2023 (Q4)	- / 0.18	0.94	-80.85% (-0.76)	―	―
Nov 16, 2023	2023 (Q3)	- / 0.30	-0.735	140.82% (+1.03)	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

GB:IDHC Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Nov 13, 2025	$0.55	$0.66	+20.00%
Sep 02, 2025	$0.47	$0.48	+2.13%
May 28, 2025	$0.34	$0.35	+2.94%
Apr 17, 2025	$0.31	$0.33	+6.45%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Integrated Diagnostics Holdings PLC (GB:IDHC) report earnings?

Integrated Diagnostics Holdings PLC (GB:IDHC) is schdueled to report earning on Apr 16, 2026, TBA (Confirmed).

What is Integrated Diagnostics Holdings PLC (GB:IDHC) earnings time?

Integrated Diagnostics Holdings PLC (GB:IDHC) earnings time is at Apr 16, 2026, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is the P/E ratio of Integrated Diagnostics Holdings PLC stock?

The P/E ratio of Integrated Diagnostics Holdings is N/A.

What is GB:IDHC EPS forecast?

Currently, no data Available

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing